RTA-404

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRTA-404
Drug Alias Nametriterpenoids (Dartmouth/MD Anderson/Reata)RTA-404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine receptors antagonists
TargetsCytokine receptors
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReata Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson DiseaseMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A